• English
  • Sign In
  • Contact Us
Catalog Products » Other Products » Stable Cell Lines » Human Recombinant CD32C 13Gln Stable Cell Line

CHO-K1/CD32C 13Gln Stable Cell Line

Synonyms CD32; FCG2; CD32C; CDW32; IGFR2; FCRIIC
Description Human studies suggest expression of CD32C could help predict patient responses to vaccines. CD32C normally contains a termination codon, but 7%–15% of individuals carry a mutation that changes it into a full-length open reading frame. Individuals with this variant expressed CD32C on B cells were more likely to respond to an anthrax vaccine than patients that did not express the variant. Individuals with the full-length CD32C variant also were more likely to develop the autoimmune disease systemic lupus erythematosus (SLE) than those without the variant.
Species human
Culture Medium F12K, 10% FBS, 8 μg/ml Puromycin
Freeze Medium 95% complete growth medium, 5% DMSO

Stability 15 passages
Storage Liquid nitrogen immediately upon receiving

Binding assay or use as immunogen

  • CHO-K1/CD32C 13Gln Stable Cell Line
  • CHO-K1/CD32C 13Gln Stable Cell Line

    FACS analysis of human CD32C 13Gln expression in CHO-K1 cells.

Notice there is no results found, you can visit "Citations Database" for other results.

For more documents, please visit "Technical Support".

Cat. No. M00601
Size Price
2 vials $8500.00

20% off your first order! Offer valid till December 31st, 2020.